Healthcare · Biotechnology
Price
$4.39
Market Cap
$228.2M
Employees
77
Beta
0.89
Avg Volume
692,369
CEO
Andrew Obenshain
Inventiva S.A. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of orally administered small molecule therapeutics. The firm primarily targets serious conditions such as non-alcoholic steatohepatitis (NASH), various forms of mucopolysaccharidoses (MPS), and other significant diseases. The company's most advanced experimental drug is Lanifibranor, which has successfully completed Phase IIb clinical trials for the treatment of NASH. Inventiva is also progressing with Odiparcil, an asset that has finished its Phase IIa clinical studies for addressing the MPS VI subtype disease. Beyond these lead candidates, Inventiva maintains a robust pipeline of earlier-stage research and development programs, notably in oncology and other therapeutic areas. The company has also established important strategic alliances, including a partnership with AbbVie focused on treatments for autoimmune diseases, and a collaboration with Boehringer Ingelheim International GmbH aimed at discovering novel therapies for idiopathic pulmonary fibrosis. Inventiva S.A. was established in 2011 and is headquartered in Daix, France.
Runs with full report
Price Overview
Last updated: Jul 8, 2026 7:19pm (just now)
Current data · timestamped when a report runs
$4.39
Change · Jul 8
-0.17 (-3.73%)
Day Range
$4.20 – $4.74
52-Week Range
$2.85 – $7.98
50-Day MA
$4.54
200-Day MA
$5.18
Volume
3,403,278.00
Analyst Price Targets
Low
$12.00
Consensus
$18.00
High
$24.00
(7 analysts)
Share Structure
Outstanding
51,982,103.00
Float
43,973,293.00
Free Float
84.6%
High free float
— 84.6% of shares trade freely, ~15.4% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-2.41
Stock Price: $4.39
EPS (Diluted): -1.82
EPS (Diluted): -1.82
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
-25.46
Stock Price: $4.39
Total Equity: -$29.04M
Shares: 186,801,792
Total Equity: -$29.04M
Shares: 186,801,792
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-3.62
Market Cap: $228.20M
Total Debt: $55.04M
Cash: $99.27M
EBITDA: -$128.15M
Total Debt: $55.04M
Cash: $99.27M
EBITDA: -$128.15M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$699.4M
Market Cap: $228.20M
Total Debt: $55.04M
Cash: $99.27M
Total Debt: $55.04M
Cash: $99.27M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
164.91
Stock Price: $4.39
Revenue: $4.48M
Shares: 186,801,792
Revenue: $4.48M
Shares: 186,801,792
EV/Sales (Total value vs revenue — works when P/E can't)
API156.02
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
33.7%
Gross Profit: $1.51M
Revenue: $4.48M
Revenue: $4.48M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-2,921.0%
Operating Income: -$130.95M
Revenue: $4.48M
Revenue: $4.48M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-7,587.8%
Net Income: -$340.16M
Revenue: $4.48M
Revenue: $4.48M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
1,870.4%
Net Income: -$340.16M
Total Equity: -$29.04M
Total Equity: -$29.04M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-66.2%
Operating Income: -$130.95M
Tax Rate: 0.0%
Equity: -$29.04M
Total Debt: $55.04M
Cash: $99.27M
Tax Rate: 0.0%
Equity: -$29.04M
Total Debt: $55.04M
Cash: $99.27M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
3.15
Current Assets: $243.84M
Current Liabilities: $77.35M
Current Liabilities: $77.35M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
-1.90
Short-Term Debt: $30.27M
Long-Term Debt: $24.77M
Total Debt: $55.04M
Total Equity: -$29.04M
Long-Term Debt: $24.77M
Total Debt: $55.04M
Total Equity: -$29.04M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$0.02
Revenue: $4.48M
Shares: 186,801,792
Shares: 186,801,792
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$-0.16
Total Equity: -$29.04M
Shares: 186,801,792
Shares: 186,801,792
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-0.54
Operating CF: -$100.98M
CapEx: -$237,255
Shares: 186,801,792
CapEx: -$237,255
Shares: 186,801,792
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $4.39
Stock Price: $4.39
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$340.16M
Net Income: -$340.16M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares IVA against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jul 7, 2026 6:18pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $4.2M | $12.2M | $17.5M | $9.2M | $4.5M |
| Cost of Revenue | $1.0M | $995,000 | $-23,000 | $3.9M | $2.8M |
| Gross Profit | $4.2M | $17.1M | $17.5M | $9.2M | $1.5M |
| Operating Expenses | $56.3M | $74.2M | $120.2M | $106.8M | $137.4M |
| Operating Income | -$52.1M | -$57.1M | -$102.7M | -$97.6M | -$130.9M |
| Net Income | -$49.6M | -$54.3M | -$110.4M | -$184.2M | -$340.2M |
| EBITDA | -$52.8M | -$56.3M | -$102.0M | -$166.5M | -$128.2M |
| EPS | $-1.27 | $-1.31 | $-2.43 | $-3.54 | $-1.82 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jul 7, 2026 6:18pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $86.6M | $86.7M | $26.9M | $96.6M | $99.3M |
| Total Current Assets | $115.6M | $106.4M | $48.2M | $111.5M | $243.8M |
| Total Assets | $122.0M | $116.0M | $69.6M | $119.0M | $248.9M |
| Current Liabilities | $22.9M | $30.7M | $50.2M | $120.7M | $77.3M |
| Long-Term Debt | $8.7M | $25.4M | $27.9M | $46.3M | $24.8M |
| Total Liabilities | $33.1M | $70.5M | $101.6M | $225.6M | $277.9M |
| Total Equity | $88.9M | $45.5M | -$32.0M | -$106.6M | -$29.0M |
| Retained Earnings | -$49.6M | -$54.3M | -$110.4M | -$184.2M | -$354.1M |
Cash Flow (Annual)
Last updated: Jul 7, 2026 6:18pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$47.6M | -$44.9M | -$81.6M | -$85.9M | -$101.0M |
| Capital Expenditure | $-534,000 | $-561,000 | $-540,000 | $-333,000 | $-237,255 |
| Free Cash Flow | -$48.2M | -$45.5M | -$82.2M | -$86.3M | -$101.2M |
| Acquisitions (net) | $89,000 | $41,000 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$19.1M | $183,000 | -$59.8M | $69.6M | $14.2M |
Analyst Estimates (Annual)
Last updated: Jul 8, 2026 7:19pm (just now)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$25.2M $25.2M – $25.2M
|
$201.7M $194.4M – $209.0M
|
$320.7M $320.7M – $320.7M
|
$570.2M $570.2M – $570.2M
|
| EBITDA |
-$25.2M -$25.2M – -$25.2M
|
-$201.7M -$209.0M – -$194.4M
|
-$320.7M -$320.7M – -$320.7M
|
-$570.2M -$570.2M – -$570.2M
|
| Net Income |
-$140.0M -$175.4M – -$104.6M
|
-$78.4M -$97.6M – -$59.1M
|
-$35.8M -$35.8M – -$35.8M
|
$89.0M $89.0M – $89.0M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jul 7, 2026 6:18pm (1d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +190.4% | +43.5% | -47.4% | -51.3% |
| Gross Profit Growth | +306.7% | +2.6% | -47.4% | -83.6% |
| Operating Income Growth | -9.6% | -79.8% | +5.0% | -34.2% |
| Net Income Growth | -9.3% | -103.5% | -66.8% | -84.7% |
| EBITDA Growth | -6.7% | -81.3% | -63.2% | +23.0% |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for IVA — it's generated by the pipeline (
market-narrative step).
No community reviews yet for IVA.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.392 · 5bda1781 · 2026-07-08 16:12:24